Published in Lancet on September 24, 1966
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
The antibody crossmatch in liver transplantation. Surgery (1986) 2.33
Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med (1970) 2.33
Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes. Clin Exp Immunol (1971) 2.06
Pros and cons for C4d as a biomarker. Kidney Int (2012) 2.03
Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys. Clin Transplant (1989) 1.74
The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56
Non-specific induction of cytotoxicity in normal human lymphocytes in vitro: studies of mechanism and specificity of the reaction. Clin Exp Immunol (1969) 1.53
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology (1992) 1.50
The effect of FK-506 on hyperacute rejection in presensitized rats. Transplant Proc (1987) 1.49
Transplantation immunology: solid organ and bone marrow. J Allergy Clin Immunol (2010) 1.30
Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction. Ann N Y Acad Sci (1975) 1.30
Successful sequential liver-kidney transplantation in a patient with performed lymphocytotoxic antibodies. Transplant Proc (1987) 1.25
Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection. J Exp Med (1990) 1.23
Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med (1990) 1.23
Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response. Ann Surg (1987) 1.19
Preformed lymphocytotoxic antibodies: the effects of class, titer and specificity on liver vs. heart allografts. Hepatology (1992) 1.18
Selective plasmapheresis in dogs for delay of heterograft response. Trans Am Soc Artif Intern Organs (1970) 1.14
The definition of ABO factors in transplantation: relation to other humoral antibody states. Transplant Proc (1987) 1.13
Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med (1995) 1.11
Platelets in hyperacute rejection of heterotopic cardiac allografts in presensitized dogs. An experimental study. Am J Pathol (1973) 1.10
Hyperacute rejection of renal homografts: with particular reference to coaglation changes, humoral antibodies, and formed blood elements. Transplant Proc (1971) 1.08
Platelets in early hyperacute allograft rejection in kidneys and their modification by sulfinpyrazone (Anturan) therapy. An experimental study. Am J Pathol (1972) 1.05
The nature of experimental second-set kidney transplant rejection. 1. The role of coagulation in hyperacute (second-set) renal allotransplant rejection in dogs. Br J Exp Pathol (1970) 1.01
Renal Transplantation in the Presence of a Positive Cytotoxic Antibody. Transplant Proc (1988) 0.99
Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation. Transplantation (1989) 0.98
Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch. Ann Surg (1996) 0.95
Regulation of allograft survival by inhibitory FcγRIIb signaling. J Immunol (2012) 0.94
Sensitized renal transplant recipients: current protocols and future directions. Nat Rev Nephrol (2010) 0.94
Studies on cellular and humoral immune factors in human renal transplantation. Ann Surg (1971) 0.93
Donor specific antibodies after transplantation. Pediatr Transplant (2011) 0.92
Antibodies and human transplant rejection. Ann Surg (1969) 0.92
Antibody mediated rejection of human liver allografts: transplantation across ABO blood group barriers. Transplant Proc (1989) 0.91
History of clinical transplantation. World J Surg (2000) 0.91
The nature of experimental second-set kidney transplant rejection. 3. The role of complement. Br J Exp Pathol (1971) 0.90
Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles. World J Surg (2000) 0.90
Immunobiological determinants in organ transplantation. Ann R Coll Surg Engl (1983) 0.90
Role of complement and NK cells in antibody mediated rejection. Hum Immunol (2012) 0.89
Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance. Am J Obstet Gynecol (2015) 0.89
The pathology of renal homograft rejection. A review. Am J Pathol (1976) 0.89
The generation and maintenance of serum alloantibody. Curr Opin Immunol (2010) 0.88
Human leukocyte antigen antibodies for monitoring transplant patients. Surg Today (2005) 0.86
Hyperacute rejection of the kidney in patients with a negative crossmatch. Transplant Proc (1988) 0.86
Hyperacute renal allograft rejection in the primate. Therapeutic limitations of antiplatelet agents alone and combined with heparin. Am J Pathol (1976) 0.86
B Cells, Antibodies, and More. Clin J Am Soc Nephrol (2015) 0.85
Allograft outcomes in outbred mice. Am J Transplant (2013) 0.85
Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol (1994) 0.85
Tissue matching and early rejection of cadaveric-donor renal allografts: the importance of unidentified donor antigens. Br Med J (1970) 0.84
Personal reflections in transplantation. Surg Clin North Am (1978) 0.84
Transfusion-associated microchimerism: the hybrid within. Transfus Med Rev (2012) 0.83
Interaction of antibody with Forssman antigen in guinea pigs. A mechanism of adaptation to antibody- and complement-mediated injury. Am J Pathol (1995) 0.83
Histologic changes in preserved cadaveric renal transplants. Am J Pathol (1977) 0.82
Varying expression of major histocompatibility complex antigens on human renal endothelium and epithelium. Br J Exp Pathol (1985) 0.82
The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors. Bone Marrow Res (2012) 0.82
Specificities of antibodies eluted from human cadaveric renal allografts. Multiple mechanisms of renal allograft injury. J Clin Invest (1981) 0.82
Issues in solid-organ transplantation in children: translational research from bench to bedside. Clinics (Sao Paulo) (2014) 0.81
Treatment options and strategies for antibody mediated rejection after renal transplantation. Semin Immunol (2011) 0.81
Patterns of vascular damage in the antibody-mediated rejection of skin xenografts in the mouse. Am J Pathol (1980) 0.81
The nature of experimental second-set kidney transplant rejection. 6. The ultrastructural features: an immunological dilemma. Br J Exp Pathol (1974) 0.81
The role of complement in the induction of acute antibody-mediated vasculitis of rat skin grafts in the mouse. Am J Pathol (1982) 0.80
The Future of Xenotransplantation. Ann Surg (1992) 0.80
Vascular endothelium as a target of immune response in renal transplant rejection. Front Immunol (2014) 0.80
Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals. Clin Exp Immunol (2001) 0.80
Assessment of the cellular immune response to HL-A antigens in human renal allograft recipients. Clin Exp Immunol (1973) 0.79
The Denver-Pittsburgh liver transplant series. Clin Transpl (1987) 0.79
Mixed lymphocyte culture in histocompatiibility testing for familial renal transplantation. Ann Surg (1972) 0.79
Organ transplantation, past and present. Surg Clin North Am (1968) 0.79
Clinical xenotransplantation. Xenotransplantation (1994) 0.78
Functional aspects of the rejection of transplanted kidneys. Calif Med (1971) 0.78
The role of antibodies in transplantation. Transplant Rev (Orlando) (2009) 0.78
Acute liver allograft antibody-mediated rejection: an inter-institutional study of significant histopathological features. Liver Transpl (2014) 0.78
Relative importance of cellular and humoral immunity in human renal transplantation. Ann Surg (1971) 0.78
Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation. Transplantation (1996) 0.78
Crossmatch testing in kidney transplantation: patterns of practice and associations with rejection and graft survival. Saudi J Kidney Dis Transpl (2009) 0.77
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. Toxins (Basel) (2014) 0.77
Experimental glomerular endothelial injury in vivo. PLoS One (2013) 0.77
Transplantation immunology of penetrating keratoplasty. Trans Am Ophthalmol Soc (1980) 0.77
The influence of cyclosporin A on alloantibody responses in inbred rats: provisional evidence for a serum factor with antiidiotypic activity. Clin Exp Immunol (1988) 0.77
Sensitized recipients exhibit accelerated but not hyperacute rejection of vascularized composite tissue allografts. Transplantation (2011) 0.76
Platelet thrombi in rejection episodes. Proc R Soc Med (1969) 0.76
Unsuccessful attempts to control hyperacute rejection of human renal homografts with F(ab') 2 and citrate organ pretreatment. Transplantation (1973) 0.76
Evaluation of the highly sensitized transplant recipient. Pediatr Nephrol (2011) 0.76
[The discovery of capillary Cd4 in kidney transplantation and the "renaissance" of humoral rejection]. Wien Klin Wochenschr (2006) 0.76
The development of clinical renal transplantation. Am J Kidney Dis (1990) 0.75
Occurrence and cross-reactivity of heterophile antibodies and anti-kidney antibodies in kidney transplanted patients and patients with renal disease. Clin Exp Immunol (1973) 0.75
Immunomodulation in transfused trauma patients. Curr Opin Anaesthesiol (2013) 0.75
Transfusion support of the transplant patient. Can Fam Physician (1988) 0.75
Organ transplantation--then and now. Hosp Physician (1987) 0.75
B Cell Immunity in Solid Organ Transplantation. Front Immunol (2017) 0.75
Organ specificity in hyperacute rejection of canine heart and kidney allografts. Ann Surg (1974) 0.75
Transplantation: the realization of a dream. Semin Nucl Med (1988) 0.75
Evaluation of the humoral immune response to human leukocyte antigens in Brazilian renal transplant candidates. PLoS One (2014) 0.75
Circulating antibodies in renal transplant recipients. Calif Med (1970) 0.75
The leucocyte migration technique as an assay of presensitization to human transplantation antigens. Clin Exp Immunol (1975) 0.75
Transplantation. Ulster Med J (1987) 0.75
Prolonged survival of renal allografts in outbred rabbits treated with donor specific F(ab')2 alloantibody. Ann Surg (1974) 0.75
Nature of hyperacute rejection. Br Med J (1973) 0.75
Histocompatibility in organ transplantation. Ann R Coll Surg Engl (1973) 0.75
Negative v positive schizophrenia. Definition and validation. Arch Gen Psychiatry (1982) 3.66
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol (2005) 3.62
Chronic renal lesions following long-term treatment with lithium. Kidney Int (1977) 2.95
Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer (1995) 2.82
Reproducibility of histomorphologic diagnoses with special reference to the kappa statistic. APMIS (1989) 2.59
Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int (2000) 1.85
Timing of postexercise protein intake is important for muscle hypertrophy with resistance training in elderly humans. J Physiol (2001) 1.69
Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation (1996) 1.41
Atrioventricular block occurring late after heart transplantation: presentation of three cases and literature review. Pacing Clin Electrophysiol (1996) 1.40
Qualitative and quantitative histopathology in transitional cell carcinomas of the urinary bladder. An international investigation of intra- and interobserver reproducibility. Lab Invest (1994) 1.39
Case for the panel. Unusual ultrastructural finding. Ultrastruct Pathol (1995) 1.39
Patient safety in developing countries: retrospective estimation of scale and nature of harm to patients in hospital. BMJ (2012) 1.33
Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32
The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30
Human transplantation antigens. Appendix: current methods in histocompatibility testing. Transplant Rev (1969) 1.27
Data on the HL-A linkage group. Ann Hum Genet (1975) 1.20
Letter: HL-A27 in acute and chronic uveitis. Lancet (1974) 1.18
Rga (Rodgers) and the HLA region: linkage and associations. Tissue Antigens (1976) 1.16
Renal biopsy findings in long-term cyclosporin treatment of psoriasis. Br J Dermatol (1997) 1.14
Assignment of the major histocompatibility complex to chromosome No. 6 in a family with a pericentric inversion. Hum Hered (1974) 1.13
Linkage of Chido and HL-A. Tissue Antigens (1974) 1.12
Successful treatment of a cardiac angiosarcoma with combined modality therapy. J Heart Lung Transplant (1995) 1.09
The epidemiology of urban pediatric neurological trauma: evaluation of, and implications for, injury prevention programs. Neurosurgery (1998) 1.09
Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies. Clin Nephrol (1994) 1.06
Genetics of the human HL-A transplantation system. Nature (1968) 1.06
PGM3: HL-A is another linkage in man. Nat New Biol (1971) 1.04
Circulating immune complexes in syphilitic nephropathy. A case report. Br J Vener Dis (1978) 1.03
Polymorphism of the HL-A system. Transplant Proc (1971) 1.03
Cortical interstitial tissue and sclerosed glomeruli in the normal human kidney, related to age and sex. A quantitative study. Virchows Arch A Pathol Anat Histol (1980) 1.02
Conical intersection dynamics in solution: the chromophore of Green Fluorescent Protein. Faraday Discuss (2004) 1.01
Morphology of ischemic acute renal failure, normal function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients. Kidney Int (1993) 1.01
Reiter's disease and HL-A 27. Lancet (1973) 1.00
On the orientation of the HL-A region and the PGM3 locus in the chromosome. Tissue Antigens (1972) 0.99
Mixed lymphocyte cultures and HL-A identity in unrelated subjects. Nature (1970) 0.97
Mixed lymphocyte cultures with inbred individuals: an approach to MLC typing. Tissue Antigens (1973) 0.96
What can we learn about patient safety from information sources within an acute hospital: a step on the ladder of integrated risk management? Qual Saf Health Care (2008) 0.96
Detection of fetal red cells in fetomaternal hemorrhage using a fetal hemoglobin monoclonal antibody by flow cytometry. Transfusion (1998) 0.96
Infective hepatitis and toxic jaundice in a municipal hospital during a five-year period. Incidence and prognosis. Acta Med Scand (1967) 0.95
HL-A antigens and heteromorphic fluorescence characters of chromosomes in prenatal paternity investigation. Nature (1972) 0.93
Glomerular ultrastructure in extracapillary glomerulonephritis. Acta Pathol Microbiol Scand Suppl (1974) 0.93
Field validation of the use of RB51 as antigen in a complement fixation test to identify calves vaccinated with Brucella abortus RB51. Clin Diagn Lab Immunol (2001) 0.93
Significance of HLA and blood-group incompatibility in spontaneous abortion. Clin Genet (1976) 0.93
Renal function and structure in albuminuric type 2 diabetic patients without retinopathy. Nephrol Dial Transplant (2001) 0.93
K+ as a vasodilator in resting human muscle: implications for exercise hyperaemia. Acta Physiol (Oxf) (2007) 0.92
Ultrastructure of the glomerular basement membrane in long term renal allografts with transplant glomerular disease. Lab Invest (1974) 0.92
Chemostat flow cell system: an in vitro model for the evaluation of antiplaque agents. J Dent Res (1994) 0.92
HLA histocompatibility antigens in open-angle glaucoma. Acta Ophthalmol (Copenh) (1978) 0.91
HL-A types in Danish Eskimos from Greenland. Tissue Antigens (1971) 0.91
Identification of a cell surface protein with a role in stimulating human keratinocyte proliferation, expressed during development and carcinogenesis. J Invest Dermatol (1997) 0.91
HL-A antigens and genes. 3. Production of HL-A typing antisera of desired specificity. Vox Sang (1969) 0.91
Ureteral complications in human renal transplantation. An analysis of 180 cases. Urol Int (1972) 0.90
Mesangial thickening and nodular glomerular sclerosis in diabetes mellitus and other diseases. Acta Pathol Microbiol Scand Suppl (1972) 0.90
Cross-reactive human HL-A isoantibodies. Nature (1968) 0.90
Irregular blood group antibodies in 200,000 individuals. Scand J Haematol (1965) 0.90
Colour vision deficiency in on of two presumably monozygotic twins with secondary amenorrhoea. Ann Hum Genet (1969) 0.89
Bf maps between the HLA--A and D loci. Tissue Antigens (1976) 0.89
A surgically induced hypoxic environment causes changes in the metastatic behaviour of tumours in vitro. Clin Exp Metastasis (2006) 0.88
On the mapping of PGM3, GLO and HLA. Tissue Antigens (1978) 0.88
The HL-A system defined with lymphocytotoxic and platelet antibodies in relation to kidney transplantation. Transplant Proc (1969) 0.88
Linkage and association studies of two phosphoglucomutase loci (PGM1 and PGM3) to eighteen other markers. Analysis of the segregation at the marker loci. Hum Hered (1970) 0.88
Morphological and functional characteristics of isolated resistance vessels in advanced uraemia. Clin Sci (Lond) (1986) 0.88
Severe reactions after cryoprecipitated human factor VIII. Vox Sang (1970) 0.88
The production of anti HL-A cytotoxic antisera through planned immunization by intravenous injection of small aliquots of whole blood. I. Immunization of unrelated recipients. Tissue Antigens (1972) 0.88
The effectiveness of active head restraint in preventing whiplash. J Trauma (2001) 0.87
Transmission of glomerulonephritis from host to human-kidney allotransplant. N Engl J Med (1966) 0.87
Cell mediated lympholysis in man. Occurrence of unexpected, HL-A (LA and FOUR) irrelevant lympholysis. Tissue Antigens (1974) 0.87
Detection of adverse events in a Scottish hospital using a consensus-based methodology. Scott Med J (2008) 0.87
Validation of the fluorescence polarization assay and comparison to other serological assays for the detection of serum antibodies to Brucella abortus in bison. J Wildl Dis (2000) 0.86
Lymphocytotoxic antisera of limited iso-specificity after skin grafting in man. Vox Sang (1968) 0.86
Renal function and renal pathology in patients with lithium-induced impairment of renal concentrating ability. Proc Eur Dial Transplant Assoc (1977) 0.86
HL-A antigens in systemic lupus erythematosus. Transplant Rev (1975) 0.86
Cell mediated lympholysis in man. The impact of HLA-C antigens. Tissue Antigens (1976) 0.85
Histocompatibility antigens on the HL-A locus in gestational choriocarcinoma. Transplant Proc (1969) 0.85
Circulating immune complexes in glomerulonephritis. Clin Nephrol (1981) 0.85
Hyperacute rejection of a kidney allograft. Scand J Urol Nephrol (1970) 0.85
Spontaneous rupture of renal transplant. Scand J Urol Nephrol (1974) 0.84
Renal transplantation in insulin-treated diabetics. Transplant Proc (1979) 0.84
Post-transfusion purpura caused by a specific platelet isoantibody. Dan Med Bull (1967) 0.84
Nomenclature for factors of the HLA system 1984. Immunogenetics (1984) 0.84
The urinary sediment after renal transplantation. Quantitative changes as an index of the activity of the renal allograft reaction. Acta Med Scand (1967) 0.84
Clinical validation and reproducibility of the Banff schema for renal allograft pathology. Transplant Proc (1995) 0.84
The HL-A system: antigenic heterogeneity and four new antigens. Tissue Antigens (1971) 0.84
Histochompatibility antigens on the HL-A locus in generalised gestational choriocarcinoma. A family study. Lancet (1968) 0.84
Internal urethrotomy with hydraulic urethral dilatations. J Urol (1971) 0.83
Reiter's disease and the histocompatibility antigen, HL-A 27. Scand J Rheumatol (1975) 0.83
Quantitative relationship between glomerular foot process width and proteinuria in glomerulonephritis. Lab Invest (1981) 0.82
Glucocorticoid regulation of natural cytotoxicity: effects of cortisol on the phenotype and function of a cloned human natural killer cell line. Cell Immunol (1997) 0.82
The Banff classification of renal allograft pathology: where do we go from here? Transplant Proc (1996) 0.82
Separation of human T and B lymphocytes using AET-treated sheep red blood cells. Transplant Proc (1979) 0.81
Ultrastructure of the glomerular basement membrane in long term renal allografts with transplant glomerular disease. Lab Invest (1974) 0.81
Extracapillary glomerulonephritis. A semiquantitative lightmicroscopical study of 59 patients. Acta Pathol Microbiol Scand Suppl (1974) 0.81
Severe functional and structural changes caused by lithium in the developing rat kidney. Acta Pathol Microbiol Immunol Scand A (1982) 0.81
HLA types in corneal diseases. Acta Ophthalmol (Copenh) (1979) 0.81